FDA Approves New Treatment for Hard-to-Treat Pancreatic Cancer

FDA approves new treatment for hard-to-treat pancreatic cancer

The U.S. Food and Drug Administration announced Wednesday the approval of a treatment for pancreatic cancer that could usher in a new era in managing one of the deadliest forms of the disease.

FDA approves breakthrough pancreatic cancer drug

The FDA has approved a new drug to treat pancreatic cancer. NPR's A Martinez speaks with Adam Feuerstein, who writes for the science and health website STAT.

FDA approves drug for pancreatic cancer that has helped Ben Sasse's survival

LINCOLN, Neb. (KLKN) – The Food and Drug Administration approved the pancreatic cancer drug Daraxonrasib on Wednesday, months ahead of schedule. The drug is an oral medication that is taken once a day. It targets the protein responsible for ramping up pancreatic cancer cells in the body. The patients who took part in the clinical trials, such as former Nebraska...

FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer

Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.

Groundbreaking drug that targets deadly type of cancer clears hurdle

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.